(19)
(11) EP 1 626 983 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
22.12.2010 Bulletin 2010/51

(45) Mention of the grant of the patent:
18.08.2010 Bulletin 2010/33

(21) Application number: 04760997.9

(22) Date of filing: 12.05.2004
(51) International Patent Classification (IPC): 
C07K 14/505(2006.01)
 A61K 47/48(2006.01)
(86) International application number:
PCT/US2004/014888
(87) International publication number:
WO 2004/101600 (25.11.2004 Gazette 2004/48)

(54)

NOVEL POLY (ETHYLENE GLYCOL) MODIFIED ERYTHROPOIETIN AGONISTS AND USES THEREOF

NEUE POLY(ETHYLENGLYCOL) MODIFIZIERTE ERYTHROPOIETINAGONISTEN UND DEREN VERWENDUNGEN

NOUVEAUX COMPOSES MODIFIES PAR DU POLY(ETHYLENE GLYCOL) ET LEURS UTILISATIONS

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 12.05.2003 US 470246 P

(43) Date of publication of application:
22.02.2006 Bulletin 2006/08

(60) Divisional application:
10173110.7

(73) Proprietor: Affymax, Inc.
Palo Alto, CA 94304 (US)

(72) Inventors:
  • HOLMES, Christopher P.
    Saratoga, CA 95070 (US)
  • TUMELTY, David
    Sunnyvale, CA 94085 (US)
  • YIN, Qun
    Palo Alto, CA 94303 (US)

(74) Representative: Icely, Dominic Michael 
Marks & Clerk LLP Oxford Business Park South 4220 Nash Court
Oxford OX4 2RU
Oxford OX4 2RU (GB)


(56) References cited: : 
EP-A- 0 400 472
WO-A-92/16221
 WO-A-00/12587
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).